Irritable bowel syndrome - pathophysiology, diagnosis, treatment. The role of low FODMAP diet
DOI:
https://doi.org/10.12775/JEHS.2022.12.09.054Keywords
irritable bowel syndrome, gut microbiota, FODMAP, low-FODMAP dietAbstract
Introduction: The gut microbiota is the microorganisms in the digestive tract. They are mainly bacteria. They play a very important role in maintaining the body's homeostasis. The state of the microbiota is influenced by lifestyle including diet, stress and physical activity. In irritable bowel syndrome, there are disorders in the composition of the intestinal microbiota. It is also associated with a disruption in the proper functioning of the gut-brain axis.
Aim: The aim of this study was to review the literature reports on irritable bowel syndrome and the impact of a low FODMAP diet.
Methods: Data for the article were retrieved using PubMed setting the time descriptors to 2017-2021.
Results and conclusions: Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disease. It is manifested by chronic abdominal pain , diarrhea or constipation and changes in the frequency of bowel movements. It significantly affects the quality of life of patients. The diagnosis uses the Roman IV criteria. Pharmacological as well as non-pharmacological methods are important in the treatment. A low-FODMAP diet plays a major role. Studies show that its proper use significantly alleviates the symptoms of IBS.
References
Mohajeri M. H., La Fata G., Steinert R. E., Weber P.: Relationship between the gut microbiome and brain function. Nutrition Reviews, Volume 76, Issue 7, July 2018, 481-496. doi: 1093/nutrit/nuy009 10.
Meng Ch., Bai Ch., Brown T. D., Hood L. E., Tian Q.: Human Gut Microbiota and Gastrointestinal Cancer. Genomics, Proteomics & Bioinformatics, Volume 16, Issue 1, February 2018, 33-49. doi: 10.1016/j.gpb.2017.06.002.
Chopyk D. M., Grakoui A.: Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders, Gastroenterology, Volume 159, Issue 3,September 2020, 849-863. doi: 10.1053/j.gastro.2020.04.077.
Dinan T. G., Cryan J. F.: Brain-Gut-Microbiota Axis and Mental Health, Psychosomatic Medicine, Volume 79, Issue 8, October 2017, 920-926.
doi: 10.1097/PSY.0000000000000519.
Herndon CC., Wang YP., Lu CL.: Targeting the gut microbiota for the treatment of irritable bowel syndrome, The Kaohsiung Journal of Medical Sciences, Volume 36, Issue 3, November 2019, 160-170. doi: 10.1002/kjm2.12154.
Defrees D. N., Bailey J.: Irritable Bowel Syndrome, Primary Care: Clinics in Office Practice, Volume 44, Issue 4, December 2017, 655-671.
doi: 10.1016/j.pop.2017.07.009.
Adriani A., Ribaldone D. G., Astegiano M., Durazzo M., Saracco G. M., Pellicano R.: Irritable bowel syndrome: the clinical approach, Panminerva Medica, Volume 60, Issue 4, December 2018, 213-222.
Lacy B. E., Patel N. K.: Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome, Journal of Clinical Medicine, Volume 6, Issue 11, October 2017, 99.
doi: 10.23736/S0031-0808.18.03541-3.
Sciavilla P., Strati F., Di Paola M., Modesto M., Vitali F., Cavalieri D., Prati G. M., Di Vito M., Aragona G., De Filippo C., Mattarelli P.: Gut microbiota profiles and characterization of cultivable fungal isolates in IBS patients, Applied Microbiology and Biotechnology, Volume 105, Issue 8, April 2021, 3277-3288.
doi: 10.1007/s00253-021-11264-4.
Lacy B. E., Pimentel M., Brenner D. M., Chey W. D., Keefer L. A., Long M. D., Moshiree B.: ACG Clinical Guideline: Management of Irritable Bowel Syndrome, The American Journal of Gastroenterology, Volume 116, Issue 1, Jaunary 2021, 17-44.
doi: 10.14309/ajg.0000000000001036.
Altobelli E., Del Negro V., Angeletti P. M., Latella G.: Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis, Nutrients, Volume 9, Issue 9, August 2017, 940. doi: 10.3390/nu9090940.
Varju P., Farkas N., Hegyi P., Garami A., Szabo I., Illes A., Solymar M., Vincze A., Balasko M., Par G., Bajor J., Szucs A., Huszar O., Pecsi D., Czimmer J.: Low fermentable oligosachharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies, PLoS One, Volume 12, Issue 8, August 2017. doi: 10.1371/journal.pone.0182942.
Patcharatrakul T., Juntrapirat A., Lakananurak N., Gonlachanvit S.: Effect of Structural Individual Low-FODMAP Dietary Advice vs. Brief Advice on a Commonly Recommended Diet on IBS Symptoms and Intestinal Gas Production, Nutrients, Volume 11, Issue 12, November 2019, 2856. doi: 10.3390/nu11122856.
Barrett J. S.: How to institute the low-FODMAP diet, Journal of Gastroenterology and Hepatology, Volume 32, Issue S1, February 2017, 8-10. doi: 10.1111/jgh.13686.
Dinan T. G., Cryan J. F.: Brain-Gut-Microbiota Axis and Mental Health, Psychosomatic Medicine, Volume 79, Issue 8, October 2017, 920-926.
doi: 10.1097/PSY.0000000000000519.
El-Salhy M., Hatlebakk J. G., Hausken T.: Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones, Nutrients, Volume 11, Issue 8, August 2019, 1824. doi: 10.3390/nu11081824.
Ooi S. L., Correa D., Pak S. Ch.: Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome – What is the current ecidence?, Complementary Therapies in Medicine, Volume 43, April 2019, 73-80. doi: 10.1016/j.ctim.2019.01.010.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ilona Gąbka, Weronika Dalmata, Jan Dąbrowski, Julita Szarpak, Marta Lipiec
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 533
Number of citations: 0
